Opioid Use Disorder Drug Approval Highlights AJPB Week in Review

Article

Top articles of the week from The American Journal of Pharmacy Benefits.

5. Study: Connected Pharmacy, Medical Benefits Improves Patient Proactivity in Healthcare

Integrated pharmacy and medical benefits may increase patient engagement in health coaching. Read more.

4. Diabetes Cure in Reach with Low-Calorie Diet

Reducing calorie intake may reverse type 2 diabetes. Read more.

3. Majority of Uninsured Patients Experienced Catastrophic Costs for Heart Attack Pre-ACA

Eighty-five percent of patients treated for heart attacks exceeded catastrophic costs before the passage of the Affordable Care Act. Read more.

2. FDA Warning: Vitamin B May Lead to Incorrect Lab Tests

Biotin interference in lab tests has resulted in at least 1 patient death. Read more.

1. Novel Opioid Use Disorder Drug Gains FDA Approval

The FDA approves the first monthly injectable buprenorphine for opioid use disoder. Read more.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Cholesterol diet and healthy food eating nutritional concept with clean fruits in nutritionist's heart dish and patient's blood sugar control record with diabetic measuring tool | Image Credit: Chinnapong - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Image credit: Goffkein | stock.adobe.com
Image credit: Wild Awake | stock.adobe.com
Image credit: Dglimages | stock.adobe.com
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Diabetes patient turn knob on end of insulin pen and dial up correct insulin dose for injection. Scale window on pen syringe showing number of units dose. Medical equipment is easy to self injection - Image credit: Orawan | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.